Bob Cook
Direttore Finanziario/CFO presso CHEETAH NET SUPPLY CHAIN SERVICE INC.
Posizioni attive di Bob Cook
Società | Posizione | Inizio | Fine |
---|---|---|---|
CHEETAH NET SUPPLY CHAIN SERVICE INC. | Direttore Finanziario/CFO | 01/10/2022 | - |
Storia della carriera di Bob Cook
Precedenti posizioni note di Bob Cook
Società | Posizione | Inizio | Fine |
---|---|---|---|
RENOVACARE, INC. | Direttore Finanziario/CFO | 22/06/2020 | 12/04/2021 |
Segretario Aziendale | 22/06/2020 | 12/04/2021 | |
CORMEDIX INC. | Comptroller/Controller/Auditor | 01/02/2017 | 31/01/2020 |
Direttore Finanziario/CFO | 01/02/2017 | 31/01/2020 | |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Direttore Finanziario/CFO | 11/01/2016 | 01/07/2016 |
STRATA SKIN SCIENCES, INC. | Direttore Finanziario/CFO | 14/04/2014 | 01/01/2016 |
Segretario Aziendale | 14/04/2014 | 01/01/2016 | |
Treasurer | 14/04/2014 | 01/01/2016 | |
IMMUNE PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/08/2013 | 01/04/2014 |
Direttore Finanziario/CFO | 01/08/2013 | 01/04/2014 | |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Direttore Amministrativo | 01/04/2004 | 21/08/2013 |
Direttore/Membro del Consiglio | 01/04/2004 | 21/08/2013 | |
Direttore Finanziario/CFO | 01/04/2004 | 21/08/2013 | |
Contatto Relazioni con gli Investitori | 01/04/2004 | 21/08/2013 | |
Public Communications Contact | 01/04/2004 | 21/08/2013 | |
Presidente | 01/04/2004 | 21/08/2013 | |
Segretario Aziendale | 01/04/2004 | 21/08/2013 | |
W WORL | Direttore Finanziario/CFO | 01/01/1998 | 01/03/2004 |
Presidente | 01/01/1998 | 01/03/2004 | |
The Chase Manhattan Bank NA
The Chase Manhattan Bank NA Major BanksFinance The Chase Manhattan Bank NA operates a commercial banking. It provides financial products, services, and advice, planning and treasury management services. The company is located in New York, NY. | Corporate Officer/Principal | 01/01/1986 | - |
Presidente | 01/01/1977 | 01/01/1995 | |
░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Bob Cook
Kogod School of Business | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Israele | 2 |
Posizioni
Director of Finance/CFO | 8 |
President | 3 |
Corporate Secretary | 3 |
Settori
Health Technology | 8 |
Finance | 3 |
Industrial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
W WORL | Health Technology |
STRATA SKIN SCIENCES, INC. | Health Technology |
CORMEDIX INC. | Health Technology |
RENOVACARE, INC. | Health Technology |
CHEETAH NET SUPPLY CHAIN SERVICE INC. | Industrial Services |
Aziende private | 5 |
---|---|
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
The Chase Manhattan Bank NA
The Chase Manhattan Bank NA Major BanksFinance The Chase Manhattan Bank NA operates a commercial banking. It provides financial products, services, and advice, planning and treasury management services. The company is located in New York, NY. | Finance |
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Health Technology |
GE Capital Commercial Finance, Inc.
GE Capital Commercial Finance, Inc. Investment ManagersFinance Part of GE Aerospace, GE Capital Commercial Finance, Inc. is an investment manager. The company is based in Glendale, CA. | Finance |
- Borsa valori
- Insiders
- Bob Cook
- Esperienza